published-canonicalcomparisonmaha-epistemic/1.0

Somatic versus germline genome editing

A boundary between edits confined to treated somatic cells and edits made in embryos or reproductive-line cells that may become heritable. This candidate preserves the experimental unit—editor or circuit, target, cell system, delivery, protocol, assay, comparator, and observation window—before any broader inference is considered.

Bounded definition

A boundary between edits confined to treated somatic cells and edits made in embryos or reproductive-line cells that may become heritable.

What the cited work establishes

The study reports CRISPR-Cas9 editing outcomes, mosaicism, and unintended events in non-viable tripronuclear human zygotes under the stated protocol.

The constructs, biological systems, protocols, assays, datasets, and comparisons reported in CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes.

Claims: urn:maha:claim:somatic-versus-germline-editing

What remains a separate question

The experiment does not establish safe or acceptable reproductive use; germline questions require distinct ethical, legal, clinical, and multigenerational evidence.

The experiment does not establish reproductive safety, heritable clinical benefit, ethical acceptability, or authorization for germline use.

Connected domain graph

Typed dependencies preserve publication state.

Only independently canonical records receive public links and relation statements. Draft graph topology remains private.

mechanistic dependencycanonical

Ex-vivo genome-editing workflow

inbound connection · method

The reported ex-vivo intervention edits somatic hematopoietic cells rather than reproductive-line cells.

strategic dependencycanonical

Ex-vivo genome-editing workflow

outbound connection · method

The cited ex-vivo hematopoietic workflow targets somatic cells and is not a germline intervention.

Claim ledger

Every proposition keeps its own evidence state.

empirical-claimsingle-study

The cited embryo study reports mosaic and unintended outcomes after CRISPR-Cas9 exposure of non-viable tripronuclear human zygotes.

Scope
The constructs, biological systems, protocols, assays, datasets, and comparisons reported in CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes.
Boundary
The experiment does not establish safe or acceptable reproductive use; germline questions require distinct ethical, legal, clinical, and multigenerational evidence.
Uncertainty
There is no universal effect estimate for this method; numerical results remain attached to the source experiment, biological system, assay, and analysis choices.
Replication
This candidate records one bounded source package. Independent replications and contradictory results must be compiled separately before evidence maturity is upgraded.

Primary sources

Citation, locator, rights, and boundary travel together.

  1. Source 1 · Protein & Cell

    CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes

    Puping Liang, Yanwen Xu, Xiya Zhang, Chenhui Ding, et al.

    Exact locator
    Abstract; Results; Tables 1–2; Methods; ethical statement.
    Establishes
    The study reports CRISPR-Cas9 editing outcomes, mosaicism, and unintended events in non-viable tripronuclear human zygotes under the stated protocol.
    Boundary
    The experiment does not establish reproductive safety, heritable clinical benefit, ethical acceptability, or authorization for germline use.
    Rights basis
    citation with paraphrase · Maha paraphrases the source-level result and links to the version of record; no article passage is reproduced.